Researchers at Indian Institute of Technology Madras (IIT-M) and Translational Health Science a...Read more
Cell and gene therapy is gaining popularity. Could you please explain what it is and specify your specific foc...Read more
SmartCardia, a renowned leader in the field of cardiac monitoring solutions, has announced an exciting partner...Read more
Bengaluru-based startup Dozee, an artificial intelligence (AI)-based contactless remote patient monitoring (RP...Read more
Allcargo Supply Chain, the contract logistics business arm of Allcargo Group, is poised for significant growth...Read more
US-based medtech firm Boston Scientific has announced the appointment of Madan Krishnan as vice president and ...Read more
Maharashtra University of Health Sciences (MUHS) has launched India’s first state-led Network of Centers...Read more
Here’s the Problem… Let me get straight to the point. Many pharma and life sciences companies th...Read more
Can organoids usher in cheap & effective cancer therapeutics?
Dozens of science and technology development payloads returned to Earth from the International Space Station (ISS) as SpaceX’s 29th Commercial Resupply Services (CRS) mission, contracted by NASA, successfully concluded on December 22, 2023. More than 30 payloads sponsored by the ISS National Laboratory returned on this mission, many of which were life science investigations aimed at benefiting humanity by improving care for patients on Earth. One among the payloads was an investigation from the University of California, San Diego (UCSD), which studied microgravity’s effects on stem-cell derived brain organoids (lab grown replicas of human organs). While this might seem like science fiction, the story of organoids dates back to 1907. Fast forward to today, these tiny replicas of human organs are experiencing a dramatic surge in popularity, transforming the face of drug discovery research. Dubbed as powerful ‘human modelling systems’, organoids are paving the way for personalised medicines and shaking up the global drug development scene. India, too, is joining the bandwagon. Let’s explore the world of organoids and how it is pushing the boundaries of personalised medicine research and precision oncology.
For Feedback, please email us at: email@example.com